The Maudsley prescribing guidelines in psychiatry DM Taylor, TRE Barnes, AH Young John Wiley & Sons, 2021 | 1717 | 2021 |
The serotonin theory of depression: a systematic umbrella review of the evidence J Moncrieff, RE Cooper, T Stockmann, S Amendola, MP Hengartner, ... Molecular psychiatry 28 (8), 3243-3256, 2023 | 686 | 2023 |
Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis C Anacker, A Cattaneo, K Musaelyan, PA Zunszain, M Horowitz, ... Proceedings of the National Academy of Sciences 110 (21), 8708-8713, 2013 | 356 | 2013 |
Tapering of SSRI treatment to mitigate withdrawal symptoms MA Horowitz, D Taylor The Lancet Psychiatry 6 (6), 538-546, 2019 | 250 | 2019 |
Stress abnormalities in individuals at risk for psychosis: a review of studies in subjects with familial risk or with “at risk” mental state G Aiello, M Horowitz, N Hepgul, CM Pariante, V Mondelli Psychoneuroendocrinology 37 (10), 1600-1613, 2012 | 184 | 2012 |
Insufficient glucocorticoid signaling and elevated inflammation in coronary heart disease patients with comorbid depression N Nikkheslat, PA Zunszain, MA Horowitz, IG Barbosa, JA Parker, ... Brain, behavior, and immunity 48, 8-18, 2015 | 157 | 2015 |
Rescue of IL-1β-induced reduction of human neurogenesis by omega-3 fatty acids and antidepressants A Borsini, S Alboni, MA Horowitz, LM Tojo, G Cannazza, KP Su, ... Brain, behavior, and immunity 65, 230-238, 2017 | 144* | 2017 |
Neuroimmune and neuroendocrine abnormalities in depression: two sides of the same coin MA Horowitz, PA Zunszain Annals of the New York Academy of Sciences 1351 (1), 68-79, 2015 | 122 | 2015 |
Chemokines in bipolar disorder: trait or state? IG Barbosa, NP Rocha, ME Bauer, AS De Miranda, RB Huguet, HJ Reis, ... European Archives of Psychiatry and Clinical Neuroscience 263, 159-165, 2013 | 120 | 2013 |
Ketamine: synaptogenesis, immunomodulation and glycogen synthase kinase-3 as underlying mechanisms of its antidepressant properties PA Zunszain, MA Horowitz, A Cattaneo, MM Lupi, CM Pariante Molecular psychiatry 18 (12), 1236-1241, 2013 | 116 | 2013 |
A method for tapering antipsychotic treatment that may minimize the risk of relapse MA Horowitz, S Jauhar, S Natesan, RM Murray, D Taylor Schizophrenia Bulletin 47 (4), 1116-1129, 2021 | 99 | 2021 |
Glucocorticoid resistance: is it a requisite for increased cytokine production in depression? A systematic review and meta-analysis AJ Perrin, MA Horowitz, J Roelofs, PA Zunszain, CM Pariante Frontiers in psychiatry 10, 423, 2019 | 85 | 2019 |
Approaches for discontinuation versus continuation of long‐term antidepressant use for depressive and anxiety disorders in adults E Van Leeuwen, ML van Driel, MA Horowitz, T Kendrick, M Donald, ... Cochrane Database of Systematic Reviews, 2021 | 84 | 2021 |
Antidepressant compounds can be both pro-and anti-inflammatory in human hippocampal cells MA Horowitz, J Wertz, D Zhu, A Cattaneo, K Musaelyan, N Nikkheslat, ... International Journal of Neuropsychopharmacology 18 (3), pyu076, 2015 | 77 | 2015 |
Glucocorticoids and Inflammation: A Double-Headed Sword in Depression? MA Horowitz, PA Zunszain, C Anacker, K Musaelyan, CM Pariante Inflammation in Psychiatry 28, 127-143, 2013 | 67 | 2013 |
The ‘patient voice’: patients who experience antidepressant withdrawal symptoms are often dismissed, or misdiagnosed with relapse, or a new medical condition A Guy, M Brown, S Lewis, M Horowitz Therapeutic Advances in Psychopharmacology 10, 2045125320967183, 2020 | 60 | 2020 |
Tapering antipsychotic treatment MA Horowitz, RM Murray, D Taylor JAMA psychiatry 78 (2), 125-126, 2021 | 41 | 2021 |
Are we repeating mistakes of the past? A review of the evidence for esketamine MA Horowitz, J Moncrieff The British Journal of Psychiatry 219 (5), 614-617, 2021 | 40 | 2021 |
Is the chemical imbalance an ‘urban legend’? An exploration of the status of the serotonin theory of depression in the scientific literature B Ang, M Horowitz, J Moncrieff SSM-Mental Health 2, 100098, 2022 | 39 | 2022 |
Distinguishing relapse from antidepressant withdrawal: clinical practice and antidepressant discontinuation studies MA Horowitz, D Taylor BJPsych advances 28 (5), 297-311, 2022 | 36 | 2022 |